Sexual transmission of human immunodeficiency virus
and relative importance of systemic factors (e.g., CD4 cell count and plasma HIV RNA concentration) and local factors (HIV), which accounts for the vast majority of new HIV infection throughout the world, occurs during rectal or vaginal inter-(e.g., presence of local infection or inflammation) as determinants of HIV DNA and RNA shedding in the anogenital tract. course, with the transfer of either free or cell-associated virus from the HIV-infected partner to the uninfected partner [1, Furthermore, although HIV has been isolated from rectal biopsies [28] , data on HIV DNA and RNA shedding from the anal-2]. As with other sexually transmitted agents, risk of sexual transmission of HIV is, in part, likely to be related to whether rectal mucosa are not yet available. To describe the determinants of anal-rectal HIV DNA and RNA and to investigate the and at what concentration the virus is present in the anogenital tract. Therefore, understanding the determinants of anogenital relationship between local and systemic factors contributing to anal-rectal HIV shedding, specimens from HIV-seropositive HIV shedding will aid in development of HIV intervention strategies. HIV detected in the anogenital tract might be either homosexual men enrolled in a prospective study of anal dysplasia were examined. transferred from plasma (RNA) or derived from HIV-infected cells present in the large aggregates of submucosal lymphoid tissue frequently present in the lower rectum and endocervix, Methods especially among those with other sexually transmitted diseases (STDs) [3 -5] .
Study population. Between October 1989 and April 1995, bisexual or homosexual men between the ages of 16 and 65 present- There are descriptions of HIV being detected (primarily by ing to the Seattle-King County Department of Public Health AIDS culture or assays for HIV DNA) in the cervix [6 -15] , male Prevention Project for HIV testing, counseling, and education reurethra [16] , and semen [17 -27] , where it has been variously garding safe sex practices, were invited to participate in a cohort associated with decreased CD4 cell count [17, 18] , increased study of HIV, anal human papillomavirus (HPV) infection, and plasma HIV RNA level [9, 19, 20] , lack of use of antiretroviral development of high-grade anal squamous intraepithelial neoplatherapy [18] , and presence of local inflammation [7, 8, 11, 12, sia, as described [29] . Follow-up visits were scheduled every 4-15]. As yet, since no one study has simultaneously examined 6 months; at each visit, subjects completed a self-administered all of these factors, we know little about the interrelationship questionnaire. The care practitioner reviewed the questionnaire, performed a detailed genital and anal-rectal examination, and collected specimens as described below. Of 468 HIV-seropositive men enrolled in this cohort, 374 had specimens available for HIV assay. General physical and detailed genital and anal-rectal examireverse transcription (RT) and amplification. After the amount of both target and standard biotinylated PCR product is measured, nations included an anoscopic examination with colposcopy. Specimens for cytology and assessment of anal-rectal inflammation the HIV RNA copy number in the plasma sample is calculated from the known input copy number of the quantitation standard. were collected as described [29] , using a dry Dacron swab; both the anal canal and lower rectal mucosa were sampled. The speciThis assay is able to detect as few as 50 copies of HIV RNA/mL of plasma. men was placed on a glass slide and immediately fixed in 95% ethanol. A second anal swab sample for analysis of anal HPV Isolation and measurement of total RNA and of HIV-1 RNA from anal swab samples. The anal swab samples for HIV RNA DNA, HIV DNA, herpes simplex virus (HSV) DNA, and cytomegalovirus (CMV) DNA was collected, ensuring that both the lower detection were collected and transported to the laboratory in 1 mL of RNA reagent (Ultraspec; Biotecx Laboratories, Houston). Total rectal mucosa and anal squamous epithelium were sampled. Samples were then placed in specimen transport medium (STM; Digene cellular RNA was isolated from 700 mL of each sample according to the manufacturer's protocol. Briefly, the sample was extracted Diagnostics, Silver Spring, MD). Finally, beginning in September 1993, an additional swab for detection of anal-rectal HIV RNA was with chloroform, the aqueous phase was ethanol-precipitated, and the RNA was suspended in buffer and treated with DNase. The collected and placed in 1 mL of a guanidinium-based collection medium, immediately placed on ice, and transported to the laboraconcentration of total RNA in the sample was determined spectrophotometrically at an absorbance of 260 nm. Total RNA (1 mg) tory. The same sequence of specimen collection was used in every patient.
was added to each HIV RT-PCR reaction. Samples that were positive for HIV RNA were tested with an HIV DNA assay. RNA Detection of anal-rectal HPV DNA, HIV DNA, HSV DNA, and CMV DNA. Each anal swab sample in STM was digested with samples positive for DNA were digested with DNase a second time, the RNA concentration was measured, and the samples were proteinase K, and the DNA was ethanol-precipitated and resuspended in Tris-EDTA buffer. Following this, the crude DNA samretested. Viral HIV-1 RNA was quantitated using a standard. This quantiple was initially evaluated by polymerase chain reaction (PCR) for the presence of HPV DNA [29] and subsequently for HIV tation standard was also used to indicate the presence of PCR inhibitors in the purified RNA samples. The precision of the assay DNA (Amplicor; Roche Diagnostic Systems, Somerville, NJ). When adequate sample remained, analyses by PCR for HSV [30] for RNA detected from the anal swab samples was determined by testing samples in duplicate both within and between runs. In our and CMV [31, 32] were also undertaken.
Detection of HPV DNA types 6, 11, 16, 18, 31, 33, 35, 39 , and laboratory, in samples frozen between initial and final testing, 18 (82%) of 22 specimens rerun to assess reproducibility showed 45 and untyped HPV. HPV DNA present in anal swab samples was detected and classified using the L1 consensus primer (MY09/ concordance of the level of HIV RNA detected (none, õ100 copies, ú100 copies), and in no case was HIV detected in one test MY11), PCR amplification, and dot blot hybridization method as described [33] .
but not the other. The limit of detection of the assay is stated by the manufacturer to be 2 copies of HIV RNA per PCR reaction. Detection of HIV DNA. Samples were analyzed for HIV DNA by a PCR amplification assay using primers SK43/SK462, which
Assays for the measurement of HIV DNA from anal swab samples. The anal swab samples for HIV DNA were collected and prime a 142-bp highly conserved region of the HIV-1 gag gene (Amplicor; Roche). PCR products were hybridized to a specific transported to the laboratory in 1 mL of STM. The samples were digested with proteinase K, and the DNA was isolated from 200 HIV probe bound to microwell plates. The HIV-specific products captured in the wells were measured, and results were compared mL of each sample. Each DNA sample (5 mg) was amplified using human b-globin primers GH20/PC04 to test the samples for adewith a cutoff value. Positive and negative controls were analyzed on each plate. quacy for PCR. Samples that were positive for b-globin DNA were then tested for HIV-1 DNA. Detection of HSV DNA. Anal swab samples were analyzed separately by a PCR amplification assay using primers HSVgB2a-Classification of anal inflammation. Smears were stained using a routine Pap stain [33] . Inflammation was identified by the number 1/HSVgB2a-2, which prime the synthesis of a 342-bp region of the gB glycoprotein gene in HSV-1 and HSV-2. Amplified HSV of polymorphonuclear leukocytes (PMNL), lymphocytes, and histiocytes, as described [5] . Briefly, the maximum number of histioproducts were detected on dot blots using the biotinylated oligonucleotide probe, HSVgB2a-P [30] .
cytes per 1400 microscopic field in at least three nonadjacent fields in the areas of densest inflammation was recorded as none, Detection of CMV DNA. CMV DNA present in anal swab samples was amplified using primers 2173/2370c, which prime 1/ (1-10), 2/ (11-29), and 3/ ( §30). The maximum number of lymphocytes per 1400 field in at least three nonadjacent fields the synthesis of a 198-bp region of exon 4 of the CMV major immediate-early gene. Amplified CMV products were detected on was recorded as none, 1/ (1-4), 2/ (5-9), and 3/ ( §10). PMNL were recorded as 0 if none were seen, 1/ if the cellular morpholdot blots using a biotinylated 90-bp DNA fragment synthesized using PCR and primers 2216/2306c [31] .
ogy of less than one-fourth of the squamous cells was obscured by PMNL, 2/ if one-fourth to one-half of the squamous cells Detection and quantitation of HIV RNA in plasma. Plasma HIV RNA was detected and quantitated in RNA samples purified were obscured, and 3/ if more than one-half of the squamous cells were obscured. Finally, the overall amount of inflammation from 200 mL of plasma sample using an HIV-1 quantitative RNA-PCR amplification and detection kit (Monitor; Roche). In this was recorded as 1 if up to one-fourth of the slide containing squamous or glandular cells also contained ú200 inflammatory cells method, a quantitation standard RNA (a synthetic RNA molecule with primer binding sites identical to those of the HIV target per high-power field (HPF), 2 if up to one-half of the slide contained ú200 inflammatory cells/HPF, 3 if from one-half to threeand a unique probe sequence, specific to the quantitation standard molecule) is added in a known amount to each sample before fourths of the slide contained ú200 inflammatory cells/HPF, and RNA level. Of the 374 men who had samples available for analysis of anal HIV DNA, 127 also had same-day anal samples 7% other ethnicity. The mean CD4 cell count among men in the sample was 523/mL; 48% had CD4 cell counts ú500/mL available for analysis of anal-rectal HIV RNA. The subset of 127 men did not differ appreciably from those not tested for and 15% had CD4 cell counts õ200/mL. Ten percent were taking antiretroviral drugs at the time of HIV DNA and RNA HIV DNA with respect to age, race, number of lifetime partners, history of STDs, CD4 cell counts, inflammation index, sampling. For men with multiple samples available for testing, the sample closest to study enrollment was tested. Of the samor detection of HSV, CMV, or HPV. The prevalence of analrectal HIV DNA present in the subset tested for HIV RNA ples available for analysis, 46% were from the enrollment study visit, while the remainder were from a subsequent follow-up was lower than in the overall group (35% vs. 55%); however, in this subset, ORs for associations between detection of analstudy visit. Anal swab samples from 12 men were unsatisfactory for HPV PCR analysis. Quantification of lymphocytes, rectal HIV DNA and inflammation, race, and rectal douching were similar to those of the overall data set. histiocytes, and PMNL in anal pap smears was possible for 318 of the 374 men.
By univariate analysis, correlates of anal-rectal RNA included both the presence (OR, 4.8; 95% CI, 1. We further examined the relationships between detections or enemas (OR, 0.6; 95% CI, 0.4 -1.0; P Å .03), and a history of syphilis (OR, 0.5; 95% CI, 0.3 -1.0; P Å .05). Other demoof anal-rectal HIV RNA and DNA and plasma HIV RNA level.
Of the 127 HIV-seropositive men tested for plasma HIV RNA graphic characteristics, sexual behaviors, current treatment with antivirals, and reported past anal examination abnormalities and anal-rectal HIV RNA and DNA, 76 (60%) had HIV DNA, HIV RNA, or both in the anal-rectal canal. Eleven men (9%) (including anal ulcers, fissures, discharge, or anal warts) did not differ between those with and without anal HIV DNA. In had only HIV DNA, 33 (26%) had both HIV DNA and RNA, and 32 (25%) had only HIV RNA in anal-rectal specimens. addition, detection of HIV DNA was not related to CD4 cell count obtained on the same day as the anal sample tested Eight men had no detectable plasma HIV RNA; of these, 1 had only anal-rectal HIV DNA, 1 had only anal-rectal HIV for HIV DNA (P Å .2). However, cytologic identification of lymphocytes (OR, 3.5; 95% CI, 1.8 -6.8; P õ .001), PMNL RNA, and the remaining 6 had neither HIV DNA nor RNA in anal-rectal specimens. As shown in ‡ Antiretroviral treatments included zidovudine alone (70%), didanosine alone (11%), zalcitabine alone (8%), or zidovudine plus didanosine and/or zalcitabine (11%).
§ Mantel-Haenszel test for trend.
x Specimens first tested for HPV and later for HIV DNA; any remaining specimen was further tested for HSV and then CMV DNA by polymerase chain reaction.
with low plasma HIV RNA levels (õ10,000 copies/mL) and Furthermore, the association between anal-rectal HIV RNA and anal-rectal DNA was significant among men with low without detectable anal-rectal HIV DNA had detectable analrectal HIV RNA, while most of those with either high levels plasma levels of HIV RNA (OR, 7.9; 95% CI, 1.6 -50.2; P Å .002), while among men with high plasma HIV RNA levels, of plasma HIV RNA ( §10,000 copies/mL) or anal-rectal HIV DNA were at increased risk for detection of anal-rectal HIV the magnitude of this association was somewhat lower (OR, 2.3; 95% CI, 0.7 -7.8; P Å .11). RNA. Among those without anal-rectal HIV DNA, the percentage of men who had detectable anal-rectal HIV RNA was
We next examined the relationships between HIV RNA copy number in anal-rectal specimens, HIV RNA plasma level, and greater among those with plasma HIV RNA levels of §10,000 copies/mL (56%), compared with those with plasma HIV RNA the presence of lymphocytes on the anal Pap smear. Among the 65 men with detectable anal-rectal HIV RNA, 46 (71%) levels of õ10,000 copies/mL (27%; OR, 3.4; 95% CI, 1.2 -9.6; P Å .009). In contrast, in those with HIV DNA in the had õ100 copies of HIV RNA/mg of total cellular RNA in the anal-rectal specimen, 18 had 100 -2500 copies/mg, and 1 had anal-rectal canal, the rate of detection of anal-rectal HIV RNA was the same among those with and without high levels of 8200 copies/mg. Although this is a relatively small sample, the HIV RNA level in anal-rectal swab samples was correlated plasma HIV RNA (75% in each group).
Thus, the risk of detecting anal-rectal HIV RNA was not with HIV RNA plasma level, as §100 copies of HIV RNA/ mg of total cellular RNA was detected in the anal-rectal swab increased among those with high compared with low plasma HIV RNA load, if HIV-infected cells were present locally.
in 16 (38%) of 42 men with §10,000 copies of RNA/mL of / 9d41$$mr32 01-12-98 08:39:52 jinfa UC: J Infect any remaining specimen was further tested for HSV and then CMV DNA by polymerase chain reaction.
x Antiretroviral treatments included zidovudine alone, didanosine alone, zalcitabine alone, or zidovudine plus didanosine and/or zalcitabine. plasma compared with 3 (13%) of 23 men with õ10,000 cop-RNA level was associated with a 2.1-fold increased odds of detecting anal HIV RNA. ies/mL of plasma (OR, 4.1; 95% CI, 1.1 -15.3; P Å .04). Detection of lymphocytes on the anal Pap smear was associated with level of anal-rectal HIV RNA (OR, 3.8; 95% CI, 1.2 -Discussion 12.6; P Å .03).
A multivariate logistic regression analysis was conducted to In this study of the determinants of anal-rectal HIV DNA and HIV RNA shedding, we found that 60% of relatively nonassess the interrelationship between local factors (the presence of inflammation and HIV-infected cells) and systemic factors
immunosuppressed HIV-infected men tested (mean CD4 cell count, 513/mL) had HIV DNA or HIV RNA (or both) detected (such as plasma HIV RNA level and CD4 cell count) as independent determinants of HIV RNA anal-rectal shedding (table  in a nodes or lymphoid aggregates [35 -38] . Our studies and those of others have demonstrated that large numbers of lymphoid follicles with germinal centers are commonly present in the anal-rectal canal. The fact that both anal-rectal HIV RNA and DNA are associated with anal-rectal inflammation (including submucosa of the lower rectum, especially in the presence of other sexually transmitted diseases [3] . Such aggregates of PMNL), independently of HIV RNA plasma load, supports the hypothesis that local infection or trauma accelerates production lymphoid tissue within the anal-rectal mucosa may be the initial site of HIV infection in most homosexual men and are likely of HIV RNA (in part) as a result of PMNL-mediated recruitment and activation of HIV-infected cells to the anal-rectal to contain a large number of HIV-infected cells. Anal-rectal biopsies from HIV-infected men in this study population freglandular mucosa. In the present study, detection of anal-rectal HIV DNA was associated with the local presence of several quently contain large lymphoid follicles exhibiting changes characteristic of HIV infection ( figure 1 ). The present study pathogens (HSV, CMV, and HPV). Our finding of a strong association between anal-rectal HIV supports the idea, suggested by a number of investigators [39, 40] , that locally produced HIV RNA (produced within subepi-DNA and anal-rectal HIV RNA among those with a low (but not among those with a high) plasma HIV RNA load suggests thelial lymphoid tissue) is an important source of virus shed into the anal-rectal canal, and that factors operating at the level that local production of HIV RNA from HIV-infected cells in the anal-rectal mucosa may be of greatest importance in of the anal-rectal lymphoid tissue (e.g., inflammation) play a major role in determining whether anal-rectal HIV shedding determining risk of transmission among men whose plasma HIV RNA load is low. Conversely, among those without analoccurs.
The association noted between HIV DNA (most of which rectal HIV DNA, the association of plasma HIV copy number with the detection of anal-rectal HIV RNA suggests that transprobably resides in mononuclear cells) and HIV RNA, independent of HIV RNA plasma levels, suggests that HIV-infected fer of HIV RNA from plasma through the anal-rectal mucosa may be an important determinant of anal-rectal HIV RNA shedmononuclear cells present in the anal-rectal submucosa are actively producing HIV RNA, which is shed into the adjacent ding. Furthermore, our data suggest that in the absence of high levels (ú10,000 copies/mL) of plasma RNA and local HIV DNA, inflammatory responses may play a role in anal-rectal rectal HIV shedding is as yet unknown. The effect of combina- † vs. reference category of inflammation index £2.
tion therapy in reducing anal-rectal HIV shedding may be re- ‡ Grouped linear analysis with CD4 cell count categorized as §500, 200 -499, or õ200 cells/mL. duced in the presence of local inflammation and its associated / 9d41$$mr32 01-12-98 08:39:52 jinfa UC: J Infect
